September 19, 2017 06:05 AM EDTUpdated 07:33 AM
People
Financing

Ex-GSK CEO, R&D chief An­drew Wit­ty and Mon­cef Slaoui are jump­ing in­to the biotech VC game

John Carroll

Editor & Founder

Top phar­ma ex­ecs at the mar­quee com­pa­nies don’t re­al­ly re­tire. Some segue quite nat­u­ral­ly in­to ven­ture cap­i­tal, where their con­tacts and heavy­weight in­dus­try rep­u­ta­tions can …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times